These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 23893244)

  • 1. PDK1 controls upstream PI3K expression and PIP3 generation.
    Dieterle AM; Böhler P; Keppeler H; Alers S; Berleth N; Drießen S; Hieke N; Pietkiewicz S; Löffler AS; Peter C; Gray A; Leslie NR; Shinohara H; Kurosaki T; Engelke M; Wienands J; Bonin M; Wesselborg S; Stork B
    Oncogene; 2014 Jun; 33(23):3043-53. PubMed ID: 23893244
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Physical association of PDK1 with AKT1 is sufficient for pathway activation independent of membrane localization and phosphatidylinositol 3 kinase.
    Ding Z; Liang J; Li J; Lu Y; Ariyaratna V; Lu Z; Davies MA; Westwick JK; Mills GB
    PLoS One; 2010 Mar; 5(3):e9910. PubMed ID: 20361045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Akt is efficiently activated by PIF-pocket- and PtdIns(3,4,5)P3-dependent mechanisms leading to resistance to PDK1 inhibitors.
    Najafov A; Shpiro N; Alessi DR
    Biochem J; 2012 Dec; 448(2):285-95. PubMed ID: 23030823
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel PI3K/Akt inhibitors screened by the cytoprotective function of human immunodeficiency virus type 1 Tat.
    Kim Y; Hollenbaugh JA; Kim DH; Kim B
    PLoS One; 2011; 6(7):e21781. PubMed ID: 21765914
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reconstitution of the mammalian PI3K/PTEN/Akt pathway in yeast.
    Rodríguez-Escudero I; Roelants FM; Thorner J; Nombela C; Molina M; Cid VJ
    Biochem J; 2005 Sep; 390(Pt 2):613-23. PubMed ID: 15913452
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Small molecule inhibition of phosphatidylinositol-3,4,5-triphosphate (PIP3) binding to pleckstrin homology domains.
    Miao B; Skidan I; Yang J; Lugovskoy A; Reibarkh M; Long K; Brazell T; Durugkar KA; Maki J; Ramana CV; Schaffhausen B; Wagner G; Torchilin V; Yuan J; Degterev A
    Proc Natl Acad Sci U S A; 2010 Nov; 107(46):20126-31. PubMed ID: 21041639
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Attenuation of the phosphatidylinositol 3-kinase/Akt signaling pathway by Porphyromonas gingivalis gingipains RgpA, RgpB, and Kgp.
    Nakayama M; Inoue T; Naito M; Nakayama K; Ohara N
    J Biol Chem; 2015 Feb; 290(8):5190-5202. PubMed ID: 25564612
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phosphatidylinositol Phosphate 5-Kinase Iγ and Phosphoinositide 3-Kinase/Akt Signaling Couple to Promote Oncogenic Growth.
    Thapa N; Choi S; Tan X; Wise T; Anderson RA
    J Biol Chem; 2015 Jul; 290(30):18843-54. PubMed ID: 26070568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. AKT-independent signaling downstream of oncogenic PIK3CA mutations in human cancer.
    Vasudevan KM; Barbie DA; Davies MA; Rabinovsky R; McNear CJ; Kim JJ; Hennessy BT; Tseng H; Pochanard P; Kim SY; Dunn IF; Schinzel AC; Sandy P; Hoersch S; Sheng Q; Gupta PB; Boehm JS; Reiling JH; Silver S; Lu Y; Stemke-Hale K; Dutta B; Joy C; Sahin AA; Gonzalez-Angulo AM; Lluch A; Rameh LE; Jacks T; Root DE; Lander ES; Mills GB; Hahn WC; Sellers WR; Garraway LA
    Cancer Cell; 2009 Jul; 16(1):21-32. PubMed ID: 19573809
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated PDK1 Expression Drives PI3K/AKT/MTOR Signaling Promotes Radiation-Resistant and Dedifferentiated Phenotype of Hepatocellular Carcinoma.
    Bamodu OA; Chang HL; Ong JR; Lee WH; Yeh CT; Tsai JT
    Cells; 2020 Mar; 9(3):. PubMed ID: 32197467
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Claspin is Required for Growth Recovery from Serum Starvation through Regulating the PI3K-PDK1-mTOR Pathway in Mammalian Cells.
    Yang CC; Masai H
    Mol Cell Biol; 2023 Jan; 43(1):1-21. PubMed ID: 36720467
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Parallel PI3K, AKT and mTOR inhibition is required to control feedback loops that limit tumor therapy.
    Sathe A; Chalaud G; Oppolzer I; Wong KY; von Busch M; Schmid SC; Tong Z; Retz M; Gschwend JE; Schulz WA; Nawroth R
    PLoS One; 2018; 13(1):e0190854. PubMed ID: 29357370
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of 3-phosphoinositide-dependent kinase 1 (PDK1) and serum- and glucocorticoid-induced protein kinase 1 (SGK1) by short-chain sphingolipid C4-ceramide rescues the trafficking defect of ΔF508-cystic fibrosis transmembrane conductance regulator (ΔF508-CFTR).
    Caohuy H; Yang Q; Eudy Y; Ha TA; Xu AE; Glover M; Frizzell RA; Jozwik C; Pollard HB
    J Biol Chem; 2014 Dec; 289(52):35953-68. PubMed ID: 25384981
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemotactic activation of Dictyostelium AGC-family kinases AKT and PKBR1 requires separate but coordinated functions of PDK1 and TORC2.
    Liao XH; Buggey J; Kimmel AR
    J Cell Sci; 2010 Mar; 123(Pt 6):983-92. PubMed ID: 20200230
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 3-phosphoinositide-dependent protein kinase-1 regulates proliferation and survival of cancer cells with an activated mitogen-activated protein kinase pathway.
    Lu Z; Cox-Hipkin MA; Windsor WT; Boyapati A
    Mol Cancer Res; 2010 Mar; 8(3):421-32. PubMed ID: 20197379
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute inhibition of PI3K-PDK1-Akt pathway potentiates insulin secretion through upregulation of newcomer granule fusions in pancreatic β-cells.
    Aoyagi K; Ohara-Imaizumi M; Nishiwaki C; Nakamichi Y; Ueki K; Kadowaki T; Nagamatsu S
    PLoS One; 2012; 7(10):e47381. PubMed ID: 23077605
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 3-Phosphoinositide-dependent kinase 1 potentiates upstream lesions on the phosphatidylinositol 3-kinase pathway in breast carcinoma.
    Maurer M; Su T; Saal LH; Koujak S; Hopkins BD; Barkley CR; Wu J; Nandula S; Dutta B; Xie Y; Chin YR; Kim DI; Ferris JS; Gruvberger-Saal SK; Laakso M; Wang X; Memeo L; Rojtman A; Matos T; Yu JS; Cordon-Cardo C; Isola J; Terry MB; Toker A; Mills GB; Zhao JJ; Murty VV; Hibshoosh H; Parsons R
    Cancer Res; 2009 Aug; 69(15):6299-306. PubMed ID: 19602588
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PDK1 Mediates
    Sambandam V; Frederick MJ; Shen L; Tong P; Rao X; Peng S; Singh R; Mazumdar T; Huang C; Li Q; Pickering CR; Myers JN; Wang J; Johnson FM
    Clin Cancer Res; 2019 Jun; 25(11):3329-3340. PubMed ID: 30770351
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Delineating the mechanism by which selenium deactivates Akt in prostate cancer cells.
    Wu Y; Zu K; Warren MA; Wallace PK; Ip C
    Mol Cancer Ther; 2006 Feb; 5(2):246-52. PubMed ID: 16505097
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclic AMP inhibits Akt activity by blocking the membrane localization of PDK1.
    Kim S; Jee K; Kim D; Koh H; Chung J
    J Biol Chem; 2001 Apr; 276(16):12864-70. PubMed ID: 11278269
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.